Cerebral venous sinus Thrombosis: Clinical Features, Long-Term outcome and recanalization.

Recanalization and prognosis of cerebral venous sinus thrombosis (CVST) are generally considered to be good, and various factors have been reported to be associated with recanalization in previous studies. Fifty patients diagnosed with CVST between September 2007 and July 2016 were analyzed retrospectively. Modified Rankin scale (mRS) scores at six months and results of follow-up imaging of patients with at least six months follow-up were also reviewed for the assessment of long term outcome, recanalization rates and factors associated with recanalization.

Factors associated with early hospital arrival in acute ischemic stroke patients.

Early diagnosis and treatment in acute ischemic stroke are crucial in terms of survival and disability. Many stroke patients remain disabled because of the treatment delay. The purpose of this study was to investigate the factors associated with the early hospital arrival in acute ischemic stroke patients.

Cryptococcal meningitis with accompanying recurrent cerebellitis in an immunocompetent patient.

This report describes a 46-year-old individual with normal immune status and a clinical course marked by headache and nausea-vomiting. He was diagnosed as having cryptococcal meningitis (CM) accompanying with cerebellitis. The interesting element was the observation of recurrent cerebellitis, never before reported in the literature for CM.

Surgical outcomes for rhinogenic contact point headaches.

Objective: To evaluate the surgical outcome in patients diagnosed as having rhinogenic contact point headaches (RCPH).

Subjects And Methods: Thirty-six patients (aged 17-58 years) with RCPH underwent mini functional endoscopic sinus surgery procedures. Patients' pain complaints were evaluated with a visual analog scale (VAS) both pre- and postoperatively.

Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.

Objectives: Matrix metalloproteinases (MMPs), particularly MMP-9, facilitate T-cell migration into the central nervous system. They play a key role in the disruption of the blood-brain barrier (BBB) and thus in the pathogenesis of multiple sclerosis. Interferon beta's (IFNbeta) ability to alter the balance between MMP-9 and MMP-9s natural inhibitor, tissue inhibitor of matrix metalloproteinase-1 (TIMP-1), may play a role in stabilizing the BBB.